HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
32.525 USD
+0.18 (+0.57%)
Overall HIMS gets a fundamental rating of 5 out of 10. We evaluated HIMS against 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.99%, HIMS belongs to the best of the industry, outperforming 83.00% of the companies in the same industry.
HIMS has a Return On Equity of 23.03%. This is amongst the best in the industry. HIMS outperforms 91.00% of its industry peers.
HIMS has a better Return On Invested Capital (5.84%) than 61.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a Profit Margin of 6.05%. This is amongst the best in the industry. HIMS outperforms 82.00% of its industry peers.
With a decent Operating Margin value of 5.96%, HIMS is doing good in the industry, outperforming 66.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 75.01%, HIMS belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 3.99 indicates that HIMS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.99, HIMS is in the better half of the industry, outperforming 76.00% of the companies in the same industry.
HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.13, HIMS is in line with its industry, outperforming 53.00% of the companies in the same industry.
HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of HIMS (1.67) is worse than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 3.99 |
ROIC/WACC0.65
WACC8.95%
2.3 Liquidity
HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.88, HIMS is in the better half of the industry, outperforming 77.00% of the companies in the same industry.
HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS's Quick ratio of 1.64 is fine compared to the rest of the industry. HIMS outperforms 67.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.73% over the past year.
The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.02%.
The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.57% yearly.
The Revenue is expected to grow by 22.77% on average over the next years. This is a very strong growth
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y28.57%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y22.77%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 60.23, HIMS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
HIMS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.25.
HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 54.28.
HIMS's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (23.98), we can say HIMS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.23 | ||
| Fwd PE | 54.28 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
The rest of the industry has a similar Price/Free Cash Flow ratio as HIMS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.97 | ||
| EV/EBITDA | 42.57 |
4.3 Compensation for Growth
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 13.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1
EPS Next 2Y5.34%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:HIMS (1/13/2026, 2:58:09 PM)
32.525
+0.18 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners94.2%
Inst Owner Change0.07%
Ins Owners5.93%
Ins Owner Change-3.31%
Market Cap7.40B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target46.4 (42.66%)
Short Float %31.63%
Short Ratio3.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-2.39%
PT rev (3m)-6.84%
EPS NQ rev (1m)-45.99%
EPS NQ rev (3m)-81.79%
EPS NY rev (1m)-3.6%
EPS NY rev (3m)-23.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.96%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.23 | ||
| Fwd PE | 54.28 | ||
| P/S | 3.35 | ||
| P/FCF | 61.97 | ||
| P/OCF | 22.78 | ||
| P/B | 12.74 | ||
| P/tB | 58.39 | ||
| EV/EBITDA | 42.57 |
EPS(TTM)0.54
EY1.66%
EPS(NY)0.6
Fwd EY1.84%
FCF(TTM)0.52
FCFY1.61%
OCF(TTM)1.43
OCFY4.39%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)1
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 3.99 |
F-Score3
WACC8.95%
ROIC/WACC0.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y28.57%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y22.77%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.26%
EBIT Next 3Y90.18%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 4 / 10.